Integrated Diagnostics Holdings plc (LON:IDHC – Get Free Report) shares hit a new 52-week high on Monday . The company traded as high as GBX 0.83 and last traded at GBX 0.79, with a volume of 140608 shares changing hands. The stock had previously closed at GBX 0.76.
Integrated Diagnostics Trading Up 3.9%
The company has a debt-to-equity ratio of 45.72, a quick ratio of 0.75 and a current ratio of 1.59. The company has a 50-day moving average price of GBX 0.67 and a 200-day moving average price of GBX 0.53. The firm has a market capitalization of £4.59 million, a price-to-earnings ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.59.
Integrated Diagnostics Company Profile
IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.
Read More
- Five stocks we like better than Integrated Diagnostics
- A month before the crash
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s Hand-Written Letter Will Shock his Haters
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
